<- Go Home
Oriola Oyj
Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tenders, real world evidence, sales support, medical translation, pharmacovigilance and medical information, and patient support services. Further, the company provides advisory services. It serves pharmaceutical companies, pharmacies, veterinarians, hospitals, healthcare providers, special stores, retailers, and e-commerce companies. The company was founded in 1907 and is headquartered in Espoo, Finland.
Market Cap
EUR 183.4M
Volume
93.8K
Cash and Equivalents
EUR 152.2M
EBITDA
EUR 11.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
EUR 167.4M
Profit Margin
8.78%
52 Week High
EUR 1.26
52 Week Low
EUR 0.95
Dividend
7.07%
Price / Book Value
1.82
Price / Earnings
-6.60
Price / Tangible Book Value
3.16
Enterprise Value
EUR 101.6M
Enterprise Value / EBITDA
-12.24
Operating Income
EUR 2.5M
Return on Equity
23.23%
Return on Assets
0.17
Cash and Short Term Investments
EUR 152.2M
Debt
EUR 70.4M
Equity
EUR 100.8M
Revenue
EUR 1.9B
Unlevered FCF
EUR 61.6M
Sector
Health Care Providers and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium